ALAINA ODOM: Open Payments
NPI 1902307978 · ALABASTER, AL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,886 in 143 payments from 17 companies in 2025. Trend: 2023 $2,557 · 2024 $3,268 · 2025 $2,886
Food & beverage: $2,886
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 43 | $730 |
| Ardelyx, Inc. | 15 | $387 |
| Takeda Pharmaceuticals U.S.A., Inc. | 12 | $233 |
| GENZYME CORPORATION | 8 | $186 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 8 | $160 |
| Phathom Pharmaceuticals, Inc. | 11 | $151 |
| Regeneron Healthcare Solutions, Inc. | 5 | $132 |
| QOL Medical, LLC | 5 | $132 |
| Ipsen Biopharmaceuticals, Inc | 5 | $129 |
| PFIZER INC. | 6 | $114 |
Products named: IBSRELA, CREON, DUPIXENT, RINVOQ, ENTYVIO, VOQUEZNA, XIFAXAN, Sucraid.
Industry payments across AL — which companies pay providers there.
